GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives $95.09 Average Price Target from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eleven brokerages that are covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $95.09.

Several equities analysts have commented on the stock. Mizuho increased their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, April 11th. HSBC assumed coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They set a "buy" rating and a $100.00 target price on the stock. Argus increased their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a research report on Monday, February 12th. Finally, UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and increased their target price for the stock from $66.00 to $88.00 in a research report on Monday, February 12th.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of GEHC. Vanguard Group Inc. lifted its stake in shares of GE HealthCare Technologies by 14.7% in the third quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company's stock valued at $3,029,917,000 after buying an additional 5,693,244 shares during the period. Norges Bank bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $229,052,000. Capital Research Global Investors lifted its stake in shares of GE HealthCare Technologies by 2.8% in the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company's stock valued at $3,969,975,000 after buying an additional 1,401,566 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of GE HealthCare Technologies by 84.4% in the third quarter. Ameriprise Financial Inc. now owns 2,668,695 shares of the company's stock valued at $181,578,000 after buying an additional 1,221,436 shares during the period. Finally, Perpetual Ltd bought a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $96,135,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 0.3 %

Shares of NASDAQ GEHC traded up $0.29 during mid-day trading on Friday, reaching $86.24. The company had a trading volume of 1,790,728 shares, compared to its average volume of 2,231,738. GE HealthCare Technologies has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a market capitalization of $39.35 billion, a PE ratio of 28.56, a price-to-earnings-growth ratio of 3.00 and a beta of 0.94. The stock's 50 day moving average is $88.92 and its 200-day moving average is $78.59.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period in the prior year, the business posted $1.31 earnings per share. GE HealthCare Technologies's revenue for the quarter was up 5.3% compared to the same quarter last year. As a group, equities analysts anticipate that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.